コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 gulated in CD8(+) T cells from patients with hepatitis delta.
2 valid surrogate endpoint in the treatment of hepatitis delta.
3 died of fulminant recurrent hepatitis B and hepatitis delta.
4 tion for fulminant recurrent hepatitis B and hepatitis delta.
5 of chronic delta hepatitis, disappearance of hepatitis delta and B virus markers, and improvement in
7 relapses may occur after PEG-IFNa therapy of hepatitis delta and thus the term sustained virological
8 ve for HBV serologic markers were tested for hepatitis delta antibody (HDAb) at 2 time periods: 1988-
9 titis delta virus (HDV) encodes one protein, hepatitis delta antigen (deltaAg), a 195-amino-acid RNA
10 anched rod structure that is associated with hepatitis delta antigen (HDAg) in cells replicating HDV.
11 e used this method to examine the effects of hepatitis delta antigen (HDAg) on the ribozyme activitie
12 by these RNAs with the virus-encoded protein hepatitis delta antigen (HDAg) perform essential roles i
13 unbranched rodlike structure of HDV RNA and hepatitis delta antigen (HDAg), a basic, disordered, oli
14 of an elongation factor, in the presence of hepatitis delta antigen (HDAg), and in the presence of t
15 ly distinct forms of the sole viral protein, hepatitis delta antigen (HDAg), from the same open readi
16 roles of the two forms of the viral protein, hepatitis delta antigen (HDAg), in HDV RNA replication a
17 iated with the sole virally encoded protein, hepatitis delta antigen (HDAg), in infected cells; howev
18 rs a single coding region whose product, the hepatitis delta antigen (HDAg), is expressed in two isof
21 ws two essential forms of the viral protein, hepatitis delta antigen (HDAg), to be synthesized from a
22 s, whereas HDV RNA encodes a single protein, hepatitis delta antigen (HDAg), which is required for vi
35 wn antiparallel coiled-coils (those from the hepatitis delta antigen (PDB ID code 1A92) and the bovin
36 ring requirement for the de novo-synthesized hepatitis delta antigen and temperature dependence, we f
37 required for production of the viral protein hepatitis delta antigen long form (HDAg-L), which is nec
38 ion, combined with our previous finding that hepatitis delta antigen mRNA synthesis is likely perform
40 raction with and incorporation of free large hepatitis delta antigen, it was partially defective in h
41 ctor SL1 could be precipitated together with hepatitis delta antigen, suggesting the association of H
44 ), which encode the small and large forms of hepatitis delta antigens (S- and L-HDAg), respectively.
45 s (simian virus 40), as well as those of the hepatitis delta enveloped virus large form antigen, with
46 to analyze the clinical long-term outcome of hepatitis delta in relation to different antiviral treat
48 ual posttreatment rate of clinical events in hepatitis delta patients eligible for PEG-IFNa therapy i
49 gth HCV cDNA plasmid containing a cis-acting hepatitis Delta ribozyme to control 3' cleavage, and inf
50 of lHDAg is required for the assembly of the hepatitis delta viral particle, these results suggest th
52 012 (amber/W site) in the antigenomic RNA of hepatitis delta virus (HDV) allows two essential forms o
54 little information on the early kinetics of hepatitis delta virus (HDV) and hepatitis B surface anti
58 ge hepatitis delta antigen (HDAg-L) mediates hepatitis delta virus (HDV) assembly and inhibits HDV RN
59 The paucity of data regarding the extent of hepatitis delta virus (HDV) associated health care burde
61 679-nt genomic and antigenomic RNAs of human hepatitis delta virus (HDV) can fold into a rod-like str
73 n (deltaAg-S and deltaAg-L, respectively) of hepatitis delta virus (HDV) differ only in the 19-aa C-t
78 dates utilize self-cleaving ribozymes of the hepatitis delta virus (HDV) family for processing their
79 The circular genome and antigenome RNAs of hepatitis delta virus (HDV) form characteristic unbranch
80 As early as 5 days after DNA copies of the hepatitis delta virus (HDV) genome or even in vitro-tran
82 transfected with a cDNA expressing a mutated hepatitis delta virus (HDV) genome that could only repli
83 elf-cleaving sequences or ribozymes from the hepatitis delta virus (HDV) genomic RNA and its compleme
94 vere form of chronic liver disease caused by hepatitis delta virus (HDV) infection superimposed on ch
95 The sera of 46 Italian patients with chronic hepatitis delta virus (HDV) infection were analyzed for
98 ed that the replication of the RNA genome of hepatitis delta virus (HDV) involves redirection of RNA
110 o genetic similarity between them.IMPORTANCE Hepatitis delta virus (HDV) is a satellite of hepatitis
128 haracterizations of genetic variations among hepatitis delta virus (HDV) isolates have focused princi
138 f the genomic and antigenomic ribozymes from hepatitis delta virus (HDV) requires divalent cation for
142 nto an oligoribonucleotide substrate for the hepatitis delta virus (HDV) ribozyme and investigated th
143 mogeneous RNA transcripts: one encodes a 3'- hepatitis delta virus (HDV) ribozyme and the other, used
144 f RNA-bound magnesium hydrate in crystals of hepatitis delta virus (HDV) ribozyme and to follow the e
149 A small ribozyme related in structure to the hepatitis delta virus (HDV) ribozyme occurs in a number
150 erous group II intron domain 5-domain 6, and hepatitis delta virus (HDV) ribozyme RNA constructs.
152 nd product forms of the cis-cleaving genomic hepatitis delta virus (HDV) ribozyme show a divalent met
161 ndary structures proposed for the cis-acting hepatitis delta virus (HDV) ribozymes contain four duple
165 m of regulation for the ribozyme activity of hepatitis delta virus (HDV) RNA in infected cells is unk
166 cleavage site in the antigenomic sequence of hepatitis delta virus (HDV) RNA is 33-nt downstream of t
169 pendent RNA replication and transcription of hepatitis delta virus (HDV) RNA, generating a full-lengt
171 ion of the 1,679-nucleotide (nt) unit-length hepatitis delta virus (HDV) RNAs in the livers of two HD
175 erase inhibitor, and phase III candidate for hepatitis delta virus (HDV) therapy, for further follow-
176 A host-mediated RNA-editing event allows hepatitis delta virus (HDV) to express two essential pro
179 We analyzed changes in hepatitis B virus and hepatitis delta virus (HDV) viral loads (VL) during teno
181 This study assessed the epidemiology of hepatitis delta virus (HDV) within the University of Uta
182 ecific drugs are currently available against hepatitis delta virus (HDV), a defective virus leading t
184 on of replication of the RNA genome of human hepatitis delta virus (HDV), a series of linear RNAs con
186 ction of primary human hepatocytes either by hepatitis delta virus (HDV), a subviral agent that uses
187 a central role in the replication scheme of hepatitis delta virus (HDV), allowing the virus to produ
192 iral agent of human hepatitis B virus (HBV), hepatitis delta virus (HDV), requires only the envelope
193 mic and antigenomic RNA strands of the human hepatitis delta virus (HDV), where they serve a crucial
195 Lacking an RNA-dependent RNA polymerase, hepatitis delta virus (HDV), which contains a circular R
196 Such difficulties can be circumvented with hepatitis delta virus (HDV), which needs the HBV large e
197 s were similar to those observed for HBV and hepatitis delta virus (HDV), which shares the same L, M,
200 ly define the breadth and specificity of the hepatitis delta virus (HDV)-specific T-cell response in
203 ized novel viruses related to coronaviruses, hepatitis delta virus and huge phages, respectively, and
204 auliflower mosaic virus 35S promoter and the hepatitis delta virus antigenomic ribozyme with a downst
220 secondary (18)O kinetic isotope effects for hepatitis delta virus ribozyme catalysis that reveal a d
222 of the T7 promoter and upstream of the human hepatitis delta virus ribozyme domain, we inserted a com
223 formed molecular dynamics simulations on the hepatitis delta virus ribozyme in the product form and a
225 NA polymerase promoter and the autocatalytic hepatitis delta virus ribozyme of a transcription plasmi
226 gth HCV cDNA plasmid containing a cis-acting hepatitis delta virus ribozyme to control 3' cleavage.
227 ectivity of the plasmid, a cDNA encoding the hepatitis delta virus ribozyme was added to the 3' end o
228 btilis RNaseP and an artificial trans-acting hepatitis delta virus ribozyme were expressed as the exo
229 solated from the antigenomic sequence of the hepatitis delta virus ribozyme with the P2 and P3 stems
230 catalytic RNAs, the hairpin ribozyme and the hepatitis delta virus ribozyme, and that the shifts are
231 eet western yellows virus pseudoknot and the hepatitis delta virus ribozyme, despite distinct structu
235 rsistently normal; after several years, both hepatitis delta virus RNA and serum HBsAg became undetec
239 RNA-protein complexes (RNPs) formed by the hepatitis delta virus RNAs and protein, HDAg, perform cr
241 ame envelope proteins, hepatitis B virus and hepatitis delta virus use the sodium/taurocholate cotran
243 titis C virus, human immunodeficiency virus, hepatitis delta virus, and alanine aminotransferase leve
245 self-cleaving RNAs: the hammerhead, hairpin, hepatitis delta virus, and in vitro-selected lead-depend
246 ween a variety of catalysts that include the hepatitis delta virus, hammerhead, X motif and Tetrahyme